Clinical Trial Update: The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer

View source ↗

Summary

A completed clinical trial evaluated whether BMI, leptin, the leptin/adiponectin ratio, and CA-15-3 can serve as reliable biomarkers for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Materno-Perinatal Hospital of the State of Mexico | Conditions: Female Breast Carcinoma | Status: COMPLETED